Influenza vaccine delay

Delays in distribution of influenza vaccine expected this season.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, July 28 (Praxis Press) A substantial delay in the distribution of influenza vaccine is anticipated for this year's flu season, according to the Advisory Committee for Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC), and implementation of organized influenza vaccination campaigns should be delayed. Annual vaccination against influenza is the primary means for minimizing serious adverse outcomes from influenza virus infections. But lower than anticipated production yields for this year's influenza A (H3N2) vaccine component and other manufacturing problems are expected to delay the distribution of influenza vaccine for the 2000-01 influenza season in the United States. The ACIP recommends that for the 2000-01 influenza season, implementation of organized influenza vaccination campaigns should be delayed but that routine influenza vaccination activities in clinics, offices, hospitals, nursing homes, and other health-care settings should proceed as normal. They also recommend that provider-specific contingency plans for an ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform